Search

everythinglearnresearchcommunity

for

Search:↓

HIV-positive patients, especially men who have sex with men, had a high rate of skin diseases and sexually transmitted infections.

Timely treatment with antibiotics and antiretrovirals can significantly improve health in HIV patients with syphilis.

A girl with symptoms like an autoimmune disorder actually had HIV and a fungal infection, which was hard to diagnose and treat, leading to her death.

Skin disorders in HIV patients have shifted, with more sexually transmitted infections and ART-related conditions now common.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

SLE is rare in Uganda but often has complications and overlaps with rheumatoid arthritis.

The document concludes that treatments like oral anti-androgens, minoxidil, and topical spironolactone can be effective for hair loss in men and women.

Adipose-derived stem cells can help repair tissue in lipodystrophy patients.

Alopecia universalis can be an early sign of HIV.

Testosterone levels are not linked to erectile dysfunction in young and middle-aged men with HIV.

Low power red laser with efavirenz can reduce HIV-1 infection to undetectable levels and improve diagnosis.

Early detection, prevention, and proper management can reduce TB-IRIS complications and deaths in HIV patients.

A new form of lipodystrophy in HIV patients causes neck fat buildup.

A woman developed Cushing syndrome and adrenal insufficiency from using fluticasone and ritonavir together.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Treatment strategies for breast cancer affect blood health, causing issues like anemia and require nutritional counseling.

A man's hair loss was linked to his HIV medication, which improved after changing drugs.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Testosterone replacement therapy significantly improved sexual interest and function in HIV+ men.

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

Isotretinoin effectively treated severe acne in HIV-positive women, with improved skin and CD4 counts, but some experienced side effects like skin dryness and hair loss.

Eclipta alba leaf alkaloids may help treat HIV by inhibiting the virus's activity.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

A new patch can deliver stable antibodies over time for potential HIV treatment.

Five FDA-approved drugs may help block COVID-19 virus entry.

The review concluded that restrictions on people with HIV/AIDS often violated their rights without proven effectiveness in stopping the virus, highlighting education as the best control method.

Plant compounds may boost antiviral treatments.